GTBP short interest
GT Biopharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 259,425 |
|---|---|
| Change vs prior report | 2,811 (+1.1%) |
| Change over six months | -65.3% |
| Days to cover | 4.41 (sector: 3.78) |
| Average daily volume | 58,776 |
| Rank in Healthcare | #473 of 922 by days to cover |
GTBP short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 259,425 | +1.1% | 4.41 | 58,776 |
| 2026-09-15 | 256,614 | -93.3% | 1.37 | 187,344 |
| 2026-08-31 | 3,842,169 | -5.4% | 9.99 | 384,595 |
| 2026-08-14 | 4,063,295 | +3.7% | 9.26 | 438,727 |
| 2026-07-31 | 3,918,534 | -18.1% | 7.75 | 505,305 |
| 2026-07-15 | 4,784,652 | +39.7% | 4.17 | 1,147,913 |
| 2026-06-30 | 3,424,425 | +35.6% | 2.42 | 1,413,329 |
| 2026-06-15 | 2,525,134 | +26.5% | 1.64 | 1,543,953 |
| 2026-05-29 | 1,996,213 | -3.8% | 1.00 | 2,006,709 |
| 2026-05-15 | 2,075,177 | +243.3% | 1.00 | 2,320,983 |
| 2026-04-30 | 604,557 | -9.9% | 1.00 | 688,008 |
| 2026-04-15 | 671,073 | -10.2% | 1.27 | 530,178 |
| 2026-03-31 | 747,375 | -26.7% | 1.14 | 654,579 |
| 2026-03-13 | 1,019,371 | -51.2% | 1.40 | 729,020 |
| 2026-02-27 | 2,089,377 | -20.5% | 2.26 | 923,696 |
| 2026-02-13 | 2,629,402 | -2.3% | 1.40 | 1,881,600 |
| 2026-01-30 | 2,691,277 | +11.0% | 3.37 | 798,754 |
| 2026-01-15 | 2,425,158 | +14.9% | 1.18 | 2,049,905 |
| 2025-12-31 | 2,111,313 | +45.3% | 1.00 | 2,660,073 |
| 2025-12-15 | 1,453,242 | -11.2% | 1.34 | 1,084,191 |
| 2025-11-28 | 1,636,186 | +14.6% | 2.00 | 818,134 |
| 2025-11-14 | 1,427,430 | +8.9% | 1.00 | 1,739,498 |
| 2025-10-31 | 1,310,410 | +25.4% | 2.25 | 581,898 |
| 2025-10-15 | 1,044,888 | +327.8% | 1.00 | 7,583,718 |
| 2025-09-30 | 244,248 | -18.4% | 1.00 | 539,761 |
import finzdata as yf
yf.Ticker("GTBP").short_interest # every report since 2017
yf.Client().short_interest(["GTBP"], start="2018-01-01")Healthcare short interest · GTBP price history · Who owns GTBP · All short interest